However, the well‐documented heterogeneity in the Aβ–tau axis wasn't taken into account, in which female sex and younger age are consistently linked to faster tau accumulation in AD, potentially leading to earlier tauopathy onset and reduced anti‐Aβ treatment efficacy.25, 26, 27, 28, 29. Here, MAPT is linked to tauopathy.